Stockpicker Comparison Tool
Nothing here is comparable yet for these companies.
Revenue Growth
CURI
22.26%
▲ 21.79%
SSP
-9.20%
▼ -7.76%
Gross Margin
CURI
72.84%
▲ 16.75%
SSP
40.03%
▲ 7.00%
Free Cash Flow
CURI
-$4.16M
▼ -$5.37M
SSP
-$2.94M
▼ -$3.29M
Net Debt / EBITDA
CURI
-0.18
▲ 1.76
SSP
-3.56
▼ -11.70
Operating Margin
CURI
39.49%
▲ 49.68%
SSP
-236.04%
▼ -240.86%
P/E Ratio
CURI
9840.34
SSP
9.76
▲ 7.63